Stocksigma LogoStocksigma Logo

Venus Remedies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 219 (+13.5% YoY | +22.3% QoQ) ■ EBITDA: 42.5 (+37.3% YoY | +24.3% QoQ) ■ EBITDA Margin (%): 19.4 (+337 bps YoY | +31 bps QoQ) ■ PAT: 25.7

Venus Remedies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Venus Remedies Ltd · Outcome · 27 Oct 2026, 12:01 am

Venus Remedies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 219 (+13.5% YoY | +22.3% QoQ) ■ EBITDA: 42.5 (+37.3% YoY | +24.3% QoQ) ■ EBITDA Margin (%): 19.4 (+337 bps YoY | +31 bps QoQ) ■ PAT: 25.7 (+27.4% YoY | +11.7% QoQ) ■ EPS (INR): 19.2 (+27.4% YoY | +11.7% QoQ)

Original exchange filing (PDF)

More announcements from Venus Remedies Ltd

All Venus Remedies Ltd announcements